Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valeria Rolih
Fighting Breast Cancer Stem Cells Through the Immune-Targeting of the xCT Cystine–glutamate Antiporter
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
The Glutamate/Cystine xCT Antiporter Antagonizes Glutamine Metabolism and Reduces Nutrient Flexibility
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury
Cellular and Molecular Gastroenterology and Hepatology
Hepatology
Gastroenterology
Extrasynaptic Glutamate Release Through Cystine/Glutamate Antiporter Contributes to Ischemic Damage
Journal of Clinical Investigation
Medicine
Retraction Note To: Suppression of the xCT–CD44v Antiporter System Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin
Breast Cancer Research and Treatment
Cancer Research
Oncology
Targeting xCT, a Cystine-Glutamate Transporter Induces Apoptosis and Tumor Regression for KSHV/HIV-associated Lymphoma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Increased Expression of Cystine/Glutamate Antiporter in Multiple Sclerosis
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Change of Cystine/Glutamate Antiporter Expression in Ethanol-Dependent Rats
Frontiers in Neuroscience
Neuroscience
Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells
Artificial Cells, Nanomedicine and Biotechnology
Medicine
Biotechnology
Biomedical Engineering
Pharmaceutical Science
Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer
Cancer Research
Oncology